CD44 and neoplasm: The transmembrane glycoprotein receptor CD44 is the major hyaluronan (HA) receptor, and the binding of CD44 to HA has been reported to modulate several phenotypic behaviors in cancer cells, including tumor progression, metastasis, and proliferation.